Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,533 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,899 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04506710 | Improvement of Communicational Skills Between Health Workers and Oncological Patients During Medical Consultative Conversations | unknown | — | 50 | I.M. Sechenov First Moscow State Medical UniversityOTHER | 1 | Jul 28, 2021 | clinicaltrials |
| NCT04192890 | Efficacy and Safety Assessment of IRE of Localized Prostate Cancer | unknown | N/A | 12 | I.M. Sechenov First Moscow State Medical UniversityOTHER | 1 | Jul 22, 2021 |
| clinicaltrials |
| NCT04953351 | MRI-Ultrasound Fusion or Cognitive Registration in MR-targeted Prostate Biopsy(PROMUC) | unknown | N/A | 470 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Jul 7, 2021 | clinicaltrials |
| NCT04926155 | The Effect of Metformin in Patients With Metastatic Castration-resistant Prostate Cancer | unknown | Phase 2 | 234 | Sun Yat-sen UniversityOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT04117594 | Whole Body Magnetic Resonance Imaging Study(WISE) | unknown | — | 50 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 19, 2021 | clinicaltrials |
| NCT04891536 | Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation Therapy(CRIOAND2021) | unknown | N/A | 100 | Ignacio Puche SanzOTHER | 1 | May 18, 2021 | clinicaltrials |
| NCT04628806 | Heat Shock Protein (HSP) 70 to Quantify and Characterize Circulating Tumor Cells(HSP70CTC) | unknown | — | 120 | Charite University, Berlin, GermanyOTHER | 1 | May 14, 2021 | clinicaltrials |
| NCT04882618 | Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer. | unknown | Phase 4 | 50 | TC Erciyes UniversityOTHER | 1 | May 12, 2021 | clinicaltrials |
| NCT03431753 | Early and Accurate Detection of Prostate Cancer in General Practice | unknown | N/A | 3,000 | Aarhus University HospitalOTHER | 1 | May 4, 2021 | clinicaltrials |
| NCT03440554 | Non-contrast MR Imaging for Whole Body Cancer Detection and Characterization | unknown | N/A | 150 | University of California, San DiegoOTHER | 1 | Apr 26, 2021 | clinicaltrials |
| NCT03396848 | Sexual Health and Rehabilitation eClinic (SHAReClinic) | unknown | N/A | 65 | University Health Network, TorontoOTHER | 1 | Apr 14, 2021 | clinicaltrials |
| NCT03876912 | The Effect of ADT on PSMA Expression in Metastatic Prostate Cancer(ADTPSMA2) | unknown | N/A | 35 | Turku University HospitalOTHER_GOV | 1 | Apr 13, 2021 | clinicaltrials |
| NCT03770351 | Early Prostate Cancer: Predicting Treatment Response | unknown | — | 693 | University of California, IrvineOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT04839055 | The Effects of Coenzyme A Combined With Abiraterone on Patients With CRPC(CoA-CRPC) | unknown | Phase 1 / Phase 2 | 50 | Jiangnan UniversityOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT04836949 | Verification of Shear Wave Elastography for DEtection of Prostate Cancer | unknown | N/A | 170 | Yonsei UniversityOTHER | 1 | Apr 8, 2021 | clinicaltrials |
| NCT04825002 | Detection of Clinically Significant Prostate Cancer Using a Urinary Multimarker Sensor | unknown | N/A | 800 | Asan Medical CenterOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT00653848 | Adjuvant Treatment of Prostate Cancer With Docetaxel or Not After Radical Radiotherapy(AdRad) | unknown | Phase 3 | 378 | Scandinavian Prostate Cancer GroupNETWORK | 1 | Mar 25, 2021 | clinicaltrials |
| NCT04783636 | To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers | unknown | Phase 1 | 40 | Peptron, Inc.INDUSTRY | 0 | Mar 17, 2021 | clinicaltrials |
| NCT04803188 | Prostate Cancer Secondary Screening in Sapienza and Policlinico Umberto I(ProSa-I) | unknown | N/A | 710 | University of Roma La SapienzaOTHER | 1 | Mar 17, 2021 | clinicaltrials |
| NCT04792138 | Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.(Histo-MRI) | unknown | — | 300 | University College, LondonOTHER | 1 | Mar 10, 2021 | clinicaltrials |
| NCT02623647 | A Phase I-II Study on Stereotactic Body Radiotherapy in 3 Fractions for Low/Int Risk Prostate Cancer(eHYPO) | unknown | N/A | 150 | Regina Elena Cancer InstituteOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT03520478 | A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer | unknown | Phase 3 | 654 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 4 | Mar 2, 2021 | clinicaltrials |
| NCT04774133 | The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients. | unknown | N/A | 50 | Regina Elena Cancer InstituteOTHER | 1 | Mar 1, 2021 | clinicaltrials |
| NCT03064282 | Prostatic Hyperplasia Treatment and Cancer Prevention | unknown | Early Phase 1 | 40 | Manchanda Medical ClinicOTHER | 0 | Feb 25, 2021 | clinicaltrials |
| NCT03943602 | Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)(CaboPen) | unknown | Phase 2 | 37 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Feb 25, 2021 | clinicaltrials |
| NCT02944201 | Beta Adrenergic Receptor Blockade as a Novel Therapy for Patients With Adenocarcinoma of the Prostate | unknown | Phase 2 | 22 | Montefiore Medical CenterOTHER | 1 | Feb 21, 2021 | clinicaltrials |
| NCT00955435 | Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15 | unknown | — | 60 | Cancer Trials IrelandNETWORK | 1 | Feb 18, 2021 | clinicaltrials |
| NCT02895854 | LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients(BRAVEROBO) | unknown | N/A | 44 | Kuopio University HospitalOTHER | 1 | Feb 18, 2021 | clinicaltrials |
| NCT04746300 | imPlementing ROutine Molecular Characterization in Patients With Metastatic Castration Resistant ProstaTe Cancer by NGS(PROMPT) | unknown | — | 400 | Radboud University Medical CenterOTHER | 1 | Feb 9, 2021 | clinicaltrials |
| NCT04736108 | Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate | unknown | Phase 2 | 50 | West China HospitalOTHER | 1 | Feb 8, 2021 | clinicaltrials |
| NCT03457805 | Prostatic Artery Embolization in Advanced Prostate Cancer | unknown | N/A | 20 | Dominik AbtOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT04017104 | Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging | unknown | — | 60 | British Columbia Cancer AgencyOTHER | 1 | Jan 26, 2021 | clinicaltrials |
| NCT00667888 | A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation | unknown | Phase 3 | 225 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 25, 2021 | clinicaltrials |
| NCT03432780 | Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate Cancer(QRT-SOGUG) | unknown | Phase 2 | 134 | Spanish Oncology Genito-Urinary GroupOTHER | 0 | Jan 22, 2021 | clinicaltrials |
| NCT04699344 | A Prospective, Single-centre，Single-blinded Study of PROUD for Prostate Carcinoma Diagnosis | unknown | — | 500 | Qilu Hospital of Shandong UniversityOTHER | 1 | Jan 7, 2021 | clinicaltrials |
| NCT04622761 | Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome(CHROME) | unknown | Phase 2 | 120 | The Clatterbridge Cancer Centre NHS Foundation TrustOTHER | 0 | Jan 5, 2021 | clinicaltrials |
| NCT04150848 | A Biobehavioral Intervention for Young Men With Testicular Cancer | unknown | Phase 2 | 100 | University of California, IrvineOTHER | 1 | Dec 19, 2020 | clinicaltrials |
| NCT04642833 | Prostate Cancer in Renal Transplants Recipients(RENPRO) | unknown | — | 30 | University of FlorenceOTHER | 1 | Dec 17, 2020 | clinicaltrials |
| NCT01835977 | Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer | unknown | Phase 2 | 106 | Clinical Research Office of the Endourological SocietyOTHER | 0 | Dec 16, 2020 | clinicaltrials |
| NCT02255890 | Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device | unknown | — | 361 | Clinical Research Office of the Endourological SocietyOTHER | 1 | Dec 14, 2020 | clinicaltrials |
| NCT03896958 | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)(PIONEER) | unknown | — | 1,000 | SpeciCareINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT00303784 | Prostate Adenocarcinoma TransCutaneous Hormones(PATCH) | unknown | Phase 3 | 2,200 | University College, LondonOTHER | 1 | Nov 27, 2020 | clinicaltrials |
| NCT01505075 | Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer(pHART8) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT01953055 | SABR Including Regional Lymph Node Irradiation for Patients With High Risk Prostate Cancer (SATURN)(SATURN) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT02031328 | Two StereoTactic Ablative Adaptive Radiotherapy Treatments for Localized Prostate Cancer(2STAR) | unknown | Phase 1 / Phase 2 | 30 | Sunnybrook Health Sciences CentreOTHER | 1 | Nov 24, 2020 | clinicaltrials |
| NCT02911636 | 5 Fractions of Pelvic SABR With Intra Prostatic SABR(5STAR) | unknown | N/A | 30 | Andrew LoblawOTHER | 0 | Nov 24, 2020 | clinicaltrials |
| NCT03307460 | uPAR-PET/MRI in Patients With Prostate Cancer for Evaluation of Tumor Aggressiveness | unknown | Phase 2 | 52 | Rigshospitalet, DenmarkOTHER | 1 | Nov 23, 2020 | clinicaltrials |
| NCT04632251 | Evaluation of the SENSEI® Laparoscopic Tethered Gamma Probe for 99mTc-nanocolloid Sentinel Lymph Node Biopsy in Prostate Cancer(LPM-012) | unknown | N/A | 56 | Lightpoint Medical LimitedINDUSTRY | 4 | Nov 17, 2020 | clinicaltrials |
| NCT04586543 | Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma | unknown | Phase 2 | 110 | László MangelOTHER | 1 | Oct 14, 2020 | clinicaltrials |
Data updated 23 days agoSource updated Jul 28, 2021source: clinicaltrials